Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin vs. Misoprostol for Secondary Prevention of Postpartum Hemorrhage
NCT05077540Unknown
- Sponsor
- Aswan University Hospital
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
01
Overview
Randomised trial of misoprostol in postpartum hemorrhage (PPH), sponsored by Aswan University Hospital. Primary endpoint: Measured blood loss ≥ 300 ml after treatment at 24 hours. Status: unknown.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05077540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05077540.